David Karli
David Karli is an American physician, academic, and entrepreneur specializing in the orthopedic applications of regenerative medicine and bioidentical hormone therapy.[1][2][3][4]
Education and Career
Karli graduated from Elizabethtown College, Pennsylvania, in 1993. He received his MD degree from the University of Maryland and completed his residency in Physical Medicine and Rehabilitation at Harvard Medical School. He joined the faculty at Harvard, serving as an attending physician with the Department of PM&R at Spaulding Rehabilitation Hospital, as well as working in the Department of Orthopedic Surgery at Massachusetts General Hospital.[1]
While working as an attending physician at Harvard Medical School, he collaborated with other orthopedic surgeons and participated in the development of rehabilitation protocols for spinal disorders. He joined the Steadman Clinic in Vail, Colorado, where he narrowed his research interest to regenerative medicine. He founded Greyledge Technologies, which focuses on autologous blood-based biotherapies for orthopedic injuries.[5][6]
References
- ↑ 1.0 1.1 "David C. Karli is Offering a New Ray of Hope Through Regenerative Medicine". RESPECT. 2020-05-01. Retrieved 2020-05-12.
- ↑ "David C. Karli, MD, MBA". TOBI Conference. 2015-06-04. Retrieved 2020-05-12.
- ↑ "Hormonal Optimization balances female Hormones, says Dr. Karli". America Daily Post. 2020-05-01. Retrieved 2020-05-12.
- ↑ "Hormonal Optimization balances female Hormones, says Dr. Karli". America Daily Post. 2020-05-01. Retrieved 2020-05-12.
- ↑ "Dr. David C. Karli's Opinion on Regenerative Medicine and Age Prevention". spacecoastdaily.com. Retrieved 2020-05-12.
- ↑ "David Karli's Vision of a Biologics-Led Future". eNEWS 2.0. 2020-05-01. Retrieved 2020-05-12.
This article "David Karli" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:David Karli. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
